As of November 6, 2026, Celcuity Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 20, 2026 to October 2, 2026 (Form 8-K, October 2, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Celcuity Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Celcuity Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-20 to 2026-10-02. Every row below is cited to the filing it comes from, and this page adds each new change as Celcuity Inc. files it.
Also on the record for Celcuity Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 11, 2026 | Stake report, Schedule 13G, by BANK OF AMERICA CORP /DE/ | 6.5% of the class | 5%+ stakes | Source |
| July 16, 2026 | Stake report, Schedule 13D/A, by Baker Bros. Advisors LP | 9.99% of the class | 5%+ stakes | Source |
| July 16, 2026 | Stake report, Schedule 13G, by Baker Bros. Advisors LP | 9.99% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by RTW Investments, LP | 6.3% of the class | 5%+ stakes | Source |
| March 24, 2026 | Stake report, Schedule 13D/A, by Baker Bros. Advisors LP | 19.99% of the class | 5%+ stakes | Source |
| March 9, 2026 | Stake report, Schedule 13D/A, by Growth Equity Opportunities 18 VGE, LLC | 4.9% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G, by Avoro Capital Advisors LLC | 6.72% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Perceptive Advisors LLC | 6.8% of the class | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Soleus Capital Management, L.P. | 3.9% of the class | 5%+ stakes | Source |
| January 16, 2026 | Stake report, Schedule 13D/A, by Growth Equity Opportunities 18 VGE, LLC | 6.3% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL | 1.6% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Brian F. Sullivan | 9.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Celcuity Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Celcuity Inc. and the records around it.
Celcuity Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Growth Equity Opportunities 18 VGE, LLC also filed stake reports on 2 other companies: Gossamer Bio, Inc. (Feb 2026), X4 Pharmaceuticals, Inc. (Oct 2025)
- Avoro Capital Advisors LLC also filed stake reports on 18 other companies: Arrowhead Pharmaceuticals, Inc. (Aug 2026), Avalo Therapeutics, Inc. (Aug 2026), Hemab Therapeutics Holdings, Inc. (Aug 2026)
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), BeOne Medicines Ltd. (Sep 2026)
Watch Celcuity Inc.
Get an email when Celcuity Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Celcuity Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Celcuity Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Celcuity Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-02 | Reported | not named in the filing | 8-K, 2026-10-02 | ||
| 2026-05-20 | Reported | not named in the filing | 8-K/A, 2026-05-20 |
New leaders reset buying decisions — get the Full Report on Celcuity Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Celcuity Inc., with the record behind each one.
Find candidates like senior executive at Celcuity Inc.Every change, in the filing's words
Reported
On October 1, 2026, the Board of Directors (the "Board") of Celcuity Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, voted to increase the size of the Board from eight members to nine members and to appoint David W. Gryska as a new director to fill the resulting vacancy, effective immediately, for a term extending through the date of the Company's 2027 Annual Meeting of Stockholders (the "2027 Annual Meeting") and the election of his successor, or his earlier death, resignation or removal.
- The Board determined that Mr. Gryska qualifies as an independent director pursuant to the listing standards of The Nasdaq Stock Market LLC and the rules of the U.S. Securities and Exchange Commission.
- The Board also appointed Mr. Gryska to serve as a member of the Audit Committee and Compensation Committee of the Board.
- Mr. Gryska will receive pro-rated compensation for his service in accordance with the Company's non-employee director compensation program, which currently provides for an annual cash retainer of $70,000, payable quarterly, and an annual equity award with a fair market value of $100,000, payable in the form of restricted stock units, stock options, or a combination of both, at the director's election.
- Upon appointment to the Board, the Company granted Mr. Gryska a pro-rated annual grant of 893 restricted stock units under the Company's 2026 Stock Incentive Plan, which will vest as to all shares upon the earlier of (i) the 2027 Annual Meeting or (ii) April 30, 2027.
Reported
On February 11, 2026, the Board of Directors (the "Board") of the Company, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "N&CG Committee"), voted to increase the size of the Board from seven members to eight members and to appoint Charles (Chip) R. Romp as a new director to fill the resulting vacancy, effective immediately, for a term extending through the date of the Company's 2026 Annual Meeting of Stockholders and the election of his successor, or his earlier death, resignation or removal.
- The Board determined that Mr. Romp qualifies as an independent director pursuant to the listing standards of The Nasdaq Stock Market LLC and the rules of the U.S. Securities and Exchange Commission (the "SEC").
- On May 14, 2026, Mr. Romp was appointed by the Board to the Compensation Committee of the Board and the N&CG Committee, effective immediately.
- Mr. Romp will receive compensation for his service in accordance with the Company's non-employee director compensation program, which currently provides for an annual cash retainer of $70,000, payable quarterly, and an annual equity award with a fair market value of $135,000, payable in the form of restricted stock, stock options, or a combination of both, at the director's election.
- Upon appointment to the Board, the Company granted Mr. Romp a pro-rated annual grant of 215 shares of restricted stock under the Company's 2017 Stock Incentive Plan, which vested in full on April 30, 2026.
Tools for this story
Each opens in a new tab, filled in for Celcuity Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.